Autolus Therapeutics (AUTL) Stock Chart & Stock Price History → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free AUTL Stock Alerts $4.39 +0.32 (+7.86%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Autolus Therapeutics Stock Price Performance5 Day Performance+9.48%1 Month Performance-8.54%3 Month Performance-35.72%6 Month Performance-1.35%Year-To-Date Performance-31.83%1 Year Performance+59.64% Receive AUTL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Autolus Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. AUTL Stock Chart for Saturday, May, 18, 2024 AUTL Chart by TradingView Autolus Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$4.07$4.39+7.86%$4.77$4.392.03 million shs$1.17 billion05/16/2024$3.93$4.07+3.56%$4.18$3.911.98 million shs$1.08 billion05/15/2024$3.93$3.93$4.21$3.92980,860 shs$1.05 billion05/14/2024$4.01$3.93-2.00%$4.13$3.901.01 million shs$1.05 billion05/13/2024$3.99$4.01+0.50%$4.02$3.751.06 million shs$1.07 billion05/10/2024$4.17$3.99-4.32%$4.26$3.911.02 million shs$1.06 billion Get the Latest News and Ratings for AUTL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Autolus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$4.11$4.17+1.46%$4.28$4.09887,247 shs$1.11 billion05/08/2024$4.01$4.11+2.49%$4.20$3.941.68 million shs$1.09 billion05/07/2024$4.08$4.01-1.72%$4.16$3.982.00 million shs$1.07 billion05/06/2024$4.19$4.08-2.63%$4.32$4.032.02 million shs$1.08 billion05/03/2024$4.11$4.19+1.95%$4.36$4.061.95 million shs$1.11 billion05/02/2024$4.00$4.11+2.75%$4.20$3.961.77 million shs$1.09 billion05/01/2024$3.68$4.00+8.70%$4.17$3.637.72 million shs$1.06 billion04/30/2024$3.80$3.68-3.16%$3.87$3.613.57 million shs$978.62 million04/29/2024$4.00$3.80-5.00%$4.14$3.795.15 million shs$1.01 billion04/26/2024$4.08$4.00-1.96%$4.15$3.992.75 million shs$1.06 billion04/25/2024$4.21$4.08-3.09%$4.29$3.963.87 million shs$1.08 billion04/24/2024$4.48$4.21-6.03%$4.60$4.152.72 million shs$1.12 billion04/23/2024$4.56$4.48-1.75%$4.71$4.481.72 million shs$1.19 billion04/22/2024$4.52$4.56+0.88%$4.65$4.481.15 million shs$1.21 billion04/19/2024$4.80$4.52-5.83%$4.84$4.491.41 million shs$1.20 billion04/18/2024$4.84$4.80-0.83%$5.25$4.791.21 million shs$1.28 billion04/17/2024$4.86$4.84-0.41%$5.05$4.83788,189 shs$1.29 billion04/16/2024$4.90$4.86-0.82%$5.00$4.84612,011 shs$1.29 billion04/15/2024$5.02$4.90-2.39%$5.18$4.86788,744 shs$1.30 billion04/12/2024$5.33$5.02-5.82%$5.34$4.981.49 million shs$1.33 billion04/11/2024$5.15$5.33+3.50%$5.41$5.17795,010 shs$1.42 billion04/10/2024$5.43$5.15-5.16%$5.38$5.15905,420 shs$1.37 billion04/09/2024$5.43$5.43$5.54$5.29492,206 shs$1.44 billion04/08/2024$5.60$5.43-3.04%$5.67$5.261.51 million shs$1.44 billion04/05/2024$5.51$5.60+1.63%$5.70$5.37703,929 shs$1.49 billion04/04/2024$5.49$5.51+0.36%$5.84$5.45685,665 shs$1.47 billion04/03/2024$5.51$5.49-0.36%$5.67$5.40883,610 shs$1.46 billion04/02/2024$5.68$5.51-2.99%$5.84$5.471.04 million shs$1.28 billion04/01/2024$6.38$5.68-10.97%$6.31$5.582.40 million shs$1.32 billion03/29/2024$6.38$6.38$6.44$6.19695,033 shs$1.48 billion03/28/2024$6.24$6.38+2.24%$6.44$6.19695,027 shs$1.48 billion03/27/2024$6.17$6.24+1.13%$6.30$6.04412,935 shs$1.45 billion03/26/2024$6.33$6.17-2.53%$6.45$6.16537,360 shs$1.43 billion03/25/2024$6.32$6.33+0.16%$6.60$6.31610,749 shs$1.47 billionPOTUS in ‘25 Not Biden/Trump, But (Ad)And I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.Click here now to see my urgent election warning.03/22/2024$6.25$6.32+1.12%$6.37$6.19513,749 shs$1.47 billion03/21/2024$6.55$6.25-4.58%$6.60$6.23684,069 shs$1.45 billion03/20/2024$6.20$6.55+5.65%$6.63$6.131.73 million shs$1.52 billion03/19/2024$6.21$6.20-0.08%$6.28$6.041.26 million shs$1.44 billion03/18/2024$5.82$6.21+6.62%$6.26$5.801.26 million shs$1.44 billion03/15/2024$5.70$5.82+2.11%$5.87$5.532.01 million shs$1.35 billion03/14/2024$5.48$5.70+4.01%$6.26$5.372.95 million shs$1.32 billion03/13/2024$5.39$5.48+1.67%$5.50$5.311.10 million shs$1.27 billion03/12/2024$5.41$5.39-0.37%$5.57$5.301.50 million shs$1.25 billion03/11/2024$5.71$5.41-5.25%$5.84$5.36904,446 shs$1.26 billion03/08/2024$5.39$5.71+5.94%$5.80$5.43999,258 shs$1.33 billion03/07/2024$5.66$5.39-4.77%$5.75$5.391.92 million shs$1.31 billion03/06/2024$5.70$5.66-0.70%$5.85$5.60623,855 shs$1.31 billion03/05/2024$5.79$5.70-1.55%$5.91$5.64862,134 shs$1.32 billion03/04/2024$6.23$5.79-7.06%$6.38$5.78945,847 shs$1.34 billion03/01/2024$6.00$6.23+3.83%$6.40$5.98808,015 shs$1.08 billion02/29/2024$5.93$6.00+1.18%$6.05$5.742.10 million shs$1.04 billion02/28/2024$6.14$5.93-3.42%$6.22$5.891.08 million shs$1.03 billion02/27/2024$6.33$6.14-3.00%$6.51$6.083.09 million shs$1.07 billion02/26/2024$6.11$6.33+3.60%$6.50$6.021.05 million shs$1.10 billion02/23/2024$6.07$6.11+0.66%$6.20$5.931.65 million shs$1.06 billion02/22/2024$6.20$6.07-2.10%$6.30$5.881.00 million shs$1.06 billion02/21/2024$6.66$6.20-6.91%$6.70$6.162.02 million shs$1.08 billion02/20/2024$6.83$6.66-2.49%$6.93$6.651.51 million shs$1.16 billion02/19/2024$6.83$6.83$7.04$6.711.24 million shs$1.19 billion Related Companies: BioCryst Pharmaceuticals Stock Chart Scholar Rock Stock Chart Mesoblast Stock Chart Immatics Stock Chart Relay Therapeutics Stock Chart Cullinan Oncology Stock Chart REGENXBIO Stock Chart Vir Biotechnology Stock Chart CARGO Therapeutics Stock Chart 4D Molecular Therapeutics Stock Chart Receive AUTL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Autolus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AUTL) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsMost important medical advance in 100 yearsThe Oxford ClubForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlace[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autolus Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.